Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Using Artificial Intelligence to Screen for Hip Dysplasia

NCT: NCT06647225 · RECRUITING

NCT IDNCT06647225
StatusRECRUITING
Start Date2024-12-06
Completion2026-11

Brief Summary

The goal of this clinical trial is to learn if an ultrasound scan using artificial intelligence can accurately screen for hip dysplasia. Researchers will compare the artificial intelligence ultrasound results to the standard ultrasound measures to see if the artificial intelligence ultrasound scan can accurately screen for hip dysplasia. It will also seek to understand how parents feel about their children undergoing this scan. Participants will: * Have an additional ultrasound performed on their child at their scheduled outpatient's appointment for hip dysplasia * Complete a short questionnaire about the experience of having the measurement performed on their child

Frequently Asked Questions

What is Using Artificial Intelligence to Screen for Hip Dysplasia?

Using Artificial Intelligence to Screen for Hip Dysplasia is a clinical trial registered under NCT06647225. Current status: RECRUITING.

What is the status of NCT06647225?

The current status of NCT06647225 (Using Artificial Intelligence to Screen for Hip Dysplasia) is: RECRUITING.

When did Using Artificial Intelligence to Screen for Hip Dysplasia start?

Using Artificial Intelligence to Screen for Hip Dysplasia started on 2024-12-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.